The number of influenza infections could be reduced by an mRNA vaccine.Credit: Science Photo Library On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older. Moderna say it will be available “in a few
August 9, 2026 — 3:00am Save You have reached your maximum number of saved items. Remove items from your saved list to add more. AAA Australia is the last continent on earth to experience cases of H5 bird flu, but with that unique status comes the key advantage of several years to formulate a plan
A new kind of flu vaccine made with mRNA technology will soon be available. Marco Bello/Bloomberg/Getty Images hide caption toggle caption Marco Bello/Bloomberg/Getty Images For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter. The Food and Drug Administration approved Moderna’s mRNA-based vaccine against seasonal influenza for people 50 and older,
Moderna will soon learn the regulatory fate of its mRNA-based flu shot. Maddie Meyer/Getty Images hide caption toggle caption Maddie Meyer/Getty Images For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter. Health Secretary Robert F Kennedy Jr. has long questioned the value of mRNA vaccine technology. And soon the Food
Prime Minister Anthony Albanese said his government had made clear to Beijing its concerns about China’s ballistic missile test. “We do not want to see any action that is destabilizing or that undermines the peace, security and stability of the Pacific and the region, and there is no doubt that this is a provocative act